Figure 1From: Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study P53 Mut , P16, and Smad4 expression in lung adenocarcinoma, shown immunohistochemically (SP × 200). (A) P53Mut positive staining detected in nucleus. (B) P16 positive staining detected in cytoplasm and nucleus. (C) Smad4 positive staining detected in cytoplasm and nucleus.Back to article page